Local
White House pulls FDA nominee Heidi Overton after wavering support from Senate Republicans
A Roundtable is a way to meet new people and discuss this article in person at a local coffee shop or other venue.
Roundtables are designed for groups of four, with a shared subject and room for everyone to speak. Come for discussion, with no dating expectation.
Source: Bangor Daily News

WASHINGTON (AP) — The White House said Tuesday it has pulled the nomination of Dr. Heidi Overton to lead the Food and Drug Administration amid growing indications she didn’t have the votes needed to win Senate confirmation. Overton, a physician and White House domestic policy adviser, has spent most of her professional career working directly for Trump or conservative groups aligned with his agenda. Her nomination in August was seen as a move to bring a stabilizing Trump loyalist to the FDA after a tumultuous year under Trump’s first FDA commissioner, Dr. Marty Makary. But Overton faced bipartisan questions in the Senate about her willingness to break from Trump, particularly on his unsupported claims about the dangers of childhood vaccines. Republican Sen. Bill Cassidy, a Louisiana doctor who chairs the Senate health committee, said earlier in the day he remained undecided about Overton ahead of a critical vote on her nomination scheduled for Wednesday.
This excerpt comes from the named source. Read the original for the full reporting.
Read the original at Bangor Daily News



